For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| General and administrative expenses | 4,953 | 83,605.5 | 39,469 | 63,964 |
| Total operating expenses | 4,953 | 83,605.5 | 39,469 | 63,964 |
| Administrative fee income | - | - | - | 0 |
| Loss from operations | -4,953 | -83,605.5* | -39,469 | -63,964 |
| Loss on disposal of equity method investment | - | -2,343,520* | - | 1,171,760 |
| Gain on derivative instrument | - | - | - | 0 |
| Relief of indebtedness income | - | -905,054* | - | -1,697,024 |
| Interest expense | 50,068 | 113,674* | 43,711 | 51,319 |
| Total other expenses | -50,068 | -1,552,140* | -43,711 | 2,817,465 |
| Gain before income taxes | -55,021 | -1,635,745.5 | -83,180 | 2,753,501 |
| Provision for income tax | - | - | - | 0 |
| Net income (gain) before equity in net gain of equity method investees | - | -1,635,745.5* | -83,180 | 2,753,501 |
| Equity in net income (gain) of equity method investees | - | -320* | 300 | 340 |
| Impairment of equity method investee, newstem | - | - | 5,432 | - |
| Income from (impairment of) equity method investee, newstem | - | 1,358* | - | - |
| Net gain | -55,021 | -1,634,707.5 | -77,448 | 2,753,841 |
| Basic EPS | 0 | -0.035 | 0 | 0.06 |
| Diluted EPS | 0 | -0.034 | 0 | 0.06 |
| Basic Average Shares | 47,384,437 | 46,881,475 | 46,881,475 | 46,881,475 |
| Diluted Average Shares | 47,384,437 | 48,738,853 | 46,881,475 | 47,765,983 |
NovelStem International Corp. (NSTM)
NovelStem International Corp. (NSTM)